Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the open-angle glaucoma (oag) market right now?

The market for open-angle glaucoma (OAG) has seen significant growth recently, and is set to increase from $6.13 billion in 2024 to $6.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The past period of growth can be ascribed to several factors including a higher incidence of glaucoma among the older demographic, heightened consciousness about the early diagnosis of eye conditions, increased healthcare spending, governmental strategies for eye care programs, and a global proliferation of ophthalmology practices.

How fast Is the open-angle glaucoma (oag) market expected to grow, and what’s its future value?

In the coming years, a substantial growth is expected in the open-angle glaucoma (OAG) market. The market is projected to reach $8.42 billion by 2029 with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth over the forecast period include a rising demand for combination therapies, increased attention to personalized medicine, better reimbursement schemes for glaucoma treatments, an uptick in lifestyle-related eye conditions, and an escalating need for non-invasive diagnostic procedures. Significant trends during the forecast period comprise a wider acceptance of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical treatments, enhanced usage of prolonged-release glaucoma implants, increased combining of wearable technology for intraocular pressure monitoring, and an elevated emphasis on sustainable practices in medical device production.

Get your open-angle glaucoma (oag) market report here!

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

What are the leading drivers of growth in the open-angle glaucoma (oag) market?

Increasing consciousness about eye diseases is predicted to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye disorders include various medical issues that affect the structure, functioning, or sight of the eyes, spanning from minor problems like dry eye to severe illnesses like glaucoma and macular degeneration. There is an increase in their occurrence owing to aging demographics, extensive screen time, rising instances of diabetes, environmental pollution, and lifestyle practices that exert pressure on eye health. Open-angle glaucoma (OAG), a primary source of blindness, particularly in the elderly, emphasizes the dire need for regular eye check-ups, early detection, and preemptive treatment to prevent permanent vision impairment. For example, the Royal National Institute of Blind People (RNIB), a vision loss charity based in the UK, reported in October 2023 that eye care outpatient visits in the UK had crossed eight million in 2021/22, rendering it the most sought-after specialty. Moreover, the count of people with vision loss, already exceeding two million, is estimated to jump to over four million by 2050. Thus, the increasing consciousness regarding eye diseases is stimulating the growth of the open-angle glaucoma (OAG) market.

What are the key segments defining the open-angle glaucoma (oag) market?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Who are the key players steering the development of the open-angle glaucoma (oag) market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

What are the key trends shaping the future of the open-angle glaucoma (oag) market?

Major companies operating in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

Which regions are most influential in expanding the open-angle glaucoma (oag) market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Antiglaucoma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Glaucoma Surgery Devices Global Market Report 2025

https://thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report

Myopia and Presbyopia Treatment Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: